Atherosclerosis is a chronic inflammatory disease and the primary cause of human death worldwide [1] . Some studies have suggested that macrophages play a critical role in the development, progression, and destabilization of atherosclerotic plaques [2] . Thus, the reduction of macrophages from plaques represents a new strategy for the treatment of atherosclerosis [3] . Sonodynamic therapy (SDT) is emerging as a new atherosclerosis treatment [4] due to the generation of free radicals by activated sonosensitizers, which can lead to apoptotic cell death. The use of gold nanoparticles (AuNPs) as the vehicle for a sensitizer delivery improves reactive oxygen species formation [5] .
